Trial Profile
Non-Inferiority Clinical Trial On The Efficacy And Safety Of Chondroitin Sulfate And Glucosamine Hydrochloride In Combination Versus Celecoxib In Patients With Knee Osteoarthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Glucosamine/chondroitin sulfate (Primary) ; Celecoxib
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Acronyms MOVES
- Sponsors Bioiberica
- 07 Sep 2015 Status changed from active, no longer recruiting to completed, according to results published in the Annals of the Rheumatic Diseases.
- 05 Mar 2015 According to a Bioiberica media release, results from this study were published in Annals of the Rheumatic Diseases.
- 19 Dec 2012 Planned End Date changed to 1 May 2013 as reported by ClinicalTrials.gov.